Search Results

Displaying Results 7101-7125 of 27381 "'S'"

Jan 19, 2026, 08:29 ET MSI Celebrates Republic Day with Tricolor of Technology Offers

world-class technology."For more details on the offers: https://msi.gm/S7FA3D77The following options are available with exciting features and offers from which customers can pick the one that best suits their needs.Brand

More news about: MSI


Jan 19, 2026, 08:12 ET IFS to partner with Sri Lanka Cricket for ICC Men's T20 World Cup 2026

https://news.cision.com/ifs/r/ifs-to-partner-with-sri-lanka-cricket-for-icc-men-s-t20-world-cup-2026,c4294415The following files are available for download:

More news about: IFS


Jan 19, 2026, 08:00 ET LANDI Global slaví 20 let inovací uvedením své nové generace platebního portfolia řady P

displej s fyzickou klávesnicí pro jistotu dotyku, zatímco řada P20-R je navržena pro spolehlivost v náročných maloobchodních prostředích.Řada P30: Kde se výkonnost plateb snoubí s pokročilým komfortem. Je postavena na úžasném 6,5palcovém HD displeji pro pohlcující zážitek, nebo s verzí

More news about: LANDI Global


Jan 19, 2026, 08:00 ET LANDI Global oslavuje 20 rokov inovácií uvedením svojho platobného portfólia novej generácie P-Series

spojenie globálneho priemyselného rozsahu a lokálnej intimity. S 20-ročnými skúsenosťami lídra na trhu a viac ako 130 miliónmi nasadených terminálov spoločnosť LANDI využíva svoje bezkonkurenčné skúsenosti na poskytovanie inovácií svetovej úrovne s odbornými znalosťami špecifickými pre daný trh, ktoré môže

More news about: LANDI Global


Jan 19, 2026, 08:00 ET KB HOME ANNOUNCES THE GRAND OPENING OF ITS NEWEST COMMUNITY IN UHLAND, TEXAS

personalized new homes with planned on-site amenities and near Texas State University and a variety of outdoor recreation, priced from the mid $200,000s.AUSTIN, Texas, Jan. 19, 2026 /PRNewswire/ -- KB Home (NYSE: KBH),

More news about: KB Home


Jan 19, 2026, 08:00 ET FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to iRegene's NouvNeu001, Making It the World's First iPSC Therapy with Both FTD and RMAT Recognitions

pivotal regulatory advancement for NouvNeu001 and a strong endorsement of its clinical value. This designation reflects the FDA's recognition of NouvNeu001's potential to address a serious unmet medical need in Parkinson's disease and provides a structured framework for deep, efficient collaboration with

More news about: iRegene Therapeutics Co., Ltd


Jan 19, 2026, 07:39 ET Smartee Denti-Technology publie son bilan de l'année 2025 : 100 000 cas de repositionnement mandibulaire fondés sur la technologie GS, expansion mondiale et développement de la production

directeur médical de Smartee, sur le traitement de la malocclusion de classe II à l'aide de gouttières transparentes à double bloc à guidage sagittal (S8-SGTB).Numéro 4, 2025 : article de recherche intitulé « Working Mechanism and Clinical Management of Mandibular Advancement Repositioning

More news about: Smartee Denti-Technology


Jan 19, 2026, 07:30 ET e& and IBM Unveil Enterprise-Grade Agentic AI to Transform Governance and Compliance

project coordination and deep familiarity with e&'s OpenPages and watsonx Assistant environment. The work showcased AI capabilities that move beyond traditional question-and-answer tools, enabling reasoning and action while remaining aligned with e&'s governance, risk, and compliance framework."Our

More news about: IBM


Jan 19, 2026, 07:09 ET Smartee Denti-Technology publica su informe anual de 2025

director médico de Smartee, sobre el tratamiento de la maloclusión de Clase II con alineadores transparentes de bloque doble guiados sagitalmente (S8-SGTB).Número 4, 2025: Artículo de investigación titulado "Mecanismo de trabajo y manejo clínico de la tecnología de reposicionamiento de

More news about: Smartee Denti-Technology


Jan 19, 2026, 07:00 ET Electricity Consumption to Rise 40% by 2035: AAPG Unites Geoscience Disciplines to Explore Real-World, Scalable Solutions

electricity consumption could rise more than 40 percent by 2035 and double by 2050. Data center demand alone could nearly double by 2030, according to S&P Global.

More news about: AAPG


Jan 19, 2026, 06:50 ET Formula 1 World Champion Sebastian Vettel to Receive One of the World's Most Prestigious Conservation Awards

https://news.cision.com/climate-aid-world-forum/i/h-s-h-prince-albert-ii-of-monaco-2022,c3501771H S H Prince Albert II of Monaco 2022

More news about: The Perfect World Foundation


Jan 19, 2026, 06:50 ET ELEGOO lancera l'imprimante 3D multicolore Centauri Carbon 2 Combo le 26 janvier

https://mma.prnewswire.com/media/2864180/ELEGOO_s_Multicolor_3D_Printer_Centauri_Carbon_2_Combo_Launch_January.jpgLogo -

More news about: Elegoo


Jan 19, 2026, 06:47 ET GLOBAL PAY - A New Era in Oman's Digital Payments Solution

financial institutions across the Middle East to deliver world-class digital experiences that drive financial inclusion."Mr. Subromoniyan K S – Managing Director, Global Money Exchange stated, "Customers can conveniently pay utility bills and educational fees without the need for a bank

More news about: Comviva


Jan 19, 2026, 06:40 ET GLOBAL PAY - A New Era in Oman's Digital Payments Solution

financial institutions across the Middle East to deliver world-class digital experiences that drive financial inclusion."Mr. Subromoniyan K S – Managing Director, Global Money Exchange stated, "Customers can conveniently pay utility bills and educational fees without the need for a bank

More news about: Comviva


Jan 19, 2026, 05:00 ET Smartee Denti-Technology Releases 2025 Year-in-Review: 100,000 GS Mandibular Repositioning Cases, Global Expansion, and Manufacturing Scale-Up

2025: A report by Dr. Xingxing Wang, Smartee Medical Director, on treatment of Class II malocclusion with sagittal-guidance twin block clear aligners (S8-SGTB).Issue 4, 2025: A research paper titled "Working Mechanism and Clinical Management of Mandibular Advancement Repositioning Technology

More news about: Smartee Denti-Technology


Jan 19, 2026, 04:50 ET ELEGOO to Launch Multicolor 3D Printer Centauri Carbon 2 Combo on January 26

https://mma.prnewswire.com/media/2864180/ELEGOO_s_Multicolor_3D_Printer_Centauri_Carbon_2_Combo_Launch_January.jpgLogo -

More news about: Elegoo


Jan 19, 2026, 04:46 ET Smartee Denti-Technology Releases 2025 Year-in-Review: 100,000 GS Mandibular Repositioning Cases, Global Expansion, and Manufacturing Scale-Up

2025: A report by Dr. Xingxing Wang, Smartee Medical Director, on treatment of Class II malocclusion with sagittal-guidance twin block clear aligners (S8-SGTB).Issue 4, 2025: A research paper titled "Working Mechanism and Clinical Management of Mandibular Advancement Repositioning Technology

More news about: Smartee Denti-Technology


Jan 19, 2026, 03:43 ET The Caravel Group Appoints Angad Banga as Group Chief Executive Officer

Asset Management. He will also lead capital allocation, strategy and investments across the Caravel enterprise. He reports to Dr. Harry S. Banga.Dr. Harry S. Banga will continue to lead The Caravel Group as Founder and Executive Chairman. In this role, Dr. Banga will focus on long-term strategy,

More news about: The Caravel Group


Jan 19, 2026, 03:09 ET F5, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - FFIV

its future growth potential even as it claimed to investors that its security practices were a major advantage in the market. Based on these facts, F5's public statements were false and materially misleading throughout the class period.If you are a shareholder who suffered a loss,

More news about: DJS Law Group LLP


Jan 19, 2026, 02:58 ET KKCG Maritime zahájí dobrovolnou nabídku na částečný odkup akcií společnosti Ferretti S.p.A.

je plně vlastněnou součástí investiční a inovační skupiny KKCG, kterou založil podnikatel a filantrop Karel Komárek. Skupina investuje vlastní kapitál s dlouhodobým, odpovědným přístupem a zaměřením na inovace a udržitelný růst napříč různými odvětvími a geografickými regiony. Akcionářem společnosti Ferretti

More news about: KKCG Maritime


Jan 19, 2026, 02:23 ET GomSpace announces 2026 market guidance with strong profitable growth

with customers in more than 60 countries. The company's business operations are mainly conducted through the wholly owned Danish subsidiary, GomSpace A/S, with headquarters and operational facilities in Aalborg, Denmark. GomSpace also has key operations in Luxembourg, France, and the United States. GomSpace

More news about: GomSpace A/S


Jan 18, 2026, 20:00 ET 德昇濟醫藥獲美國 FDA 批准兩項 IND 申請,推進 D3S-003 開展 I 期臨床試驗,並啟動 Elisrasib(D3S-001)與 D3S-002 的 II 期聯合用藥臨床試驗

D3S-003 —— KRAS G12D 抑制劑 —— 獲批後將啟動 I 期首次人體(first-in-human)臨床試驗。一項 II 期臨床試驗:評估 D3S-001(elisrasib)(公司新一代 KRAS G12C 抑制劑)與 D3S-002(選擇性口服 ERK1/2 抑制劑)的聯合用藥。D3S-003 為口服生物利用度良好的、等位基因特異性 KRAS G12D 抑制劑,可同時作用於 KRAS 的 GDP 結合(OFF)與 GTP 結合(ON)兩種構象。臨床前數據顯示,D3S-003 具備差異化、同類最佳(best-in-class)潛力,表現出優異的抗腫瘤活性、良好的類藥性特徵以及具有前景的安全窗口。獲得

More news about: 德昇濟醫藥(D3 Bio)


Jan 18, 2026, 20:00 ET D3 Bio Receives U.S. FDA Clearance for Two IND Applications, Enabling Phase 1 Trial of D3S‑003 and Phase 2 Combination Study of Elisrasib (D3S‑001) with D3S‑002

D3S‑003 — a KRAS G12D inhibitor — enabling the start of a Phase 1 first‑in‑human clinical trial.A Phase 2 combination trial evaluating D3S‑001 (elisrasib), the Company's next‑generation KRAS G12C inhibitor, in combination with D3S‑002, a selective oral ERK1/2 inhibitor.D3S‑003

More news about: D3 Bio


Jan 18, 2026, 19:30 ET AbelZeta Announces Remaining China Rights to GPC3 Armored CAR-T Therapy to be Acquired by AstraZeneca

novel cell therapies in solid tumors of high unmet medical need, including Hepatocellular carcinoma (HCC), and provides the opportunity to maximize C-CAR031's global reach" said Tony (Bizuo) Liu, Chairman and CEO of AbelZeta.C-CAR031 is an autologous, Glypican 3 (GPC3)-targeting chimeric antigen

More news about: AbelZeta Pharma, Inc.


Jan 18, 2026, 14:40 ET Class Action Announcement BBWI: A Securities Fraud Class Action Lawsuit Was Filed Against Bath & Body Works, Inc. (BBWI)

Honor Roll of Most Feared Law Firms, The Legal Intelligencer's Class Action Firm of the Year, Lawdragon's Leading Plaintiff Financial Lawyers, and Law360's Titans of the Plaintiffs Bar.  The firm operates globally with offices in Pennsylvania and California.  For more information about Kessler Topaz Meltzer

More news about: Kessler Topaz Meltzer & Check, LLP


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.